How cure rates drive patients' preference for urethral bulking agent or mid-urethral sling surgery as therapy for stress urinary incontinence.

MLA

Casteleijn, Fenne M., et al. “How Cure Rates Drive Patients’ Preference for Urethral Bulking Agent or Mid-Urethral Sling Surgery as Therapy for Stress Urinary Incontinence.” Neurourology and Urodynamics, vol. 38, no. 5, June 2019, pp. 1384–91. EBSCOhost, https://doi.org/10.1002/nau.23997.

APA

Casteleijn, F. M., Enklaar, R. A., El Bouyahyaoui, I., Jeffery, S., Zwolsman, S. E., & Roovers, J.-P. W. R. (2019). How cure rates drive patients’ preference for urethral bulking agent or mid-urethral sling surgery as therapy for stress urinary incontinence. Neurourology and Urodynamics, 38(5), 1384–1391. https://doi.org/10.1002/nau.23997

Chicago

Casteleijn, Fenne M, Rosa A Enklaar, Ikram El Bouyahyaoui, Stephen Jeffery, Sandra E Zwolsman, and Jan-Paul W R Roovers. 2019. “How Cure Rates Drive Patients’ Preference for Urethral Bulking Agent or Mid-Urethral Sling Surgery as Therapy for Stress Urinary Incontinence.” Neurourology and Urodynamics 38 (5): 1384–91. doi:10.1002/nau.23997.